guadecitabine in higher-risk mds/cmml: a phase ii trial
Published 6 months ago • 134 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
1:39
quantum-first: flt3-itd-specific mrd clearance is associated with improved os in newly diagnosed aml
-
0:47
overview of the phase iii enhance trial schema
-
4:27
the unmet needs in al amyloidosis and limitations of the current soc
-
2:43
the importance of the mdt to provide adequate treatment and care to patients with amyloidosis
-
3:23
novel agents and clinical trials emerging for the treatment of al amyloidosis
-
25:56
lecture: cusp overlap and commissural alignment in tavr
-
12:49
3mensio ct pre-case planning: valve-in-valve tavr in homograft
-
19:50
3mensio ct pre-case planning: redo-tavr with prior evolut pro
-
1:03
insights into the cartitude-6 trial: rationale and design
-
4:10
updates in al amyloidosis
-
2:07
3d restoration planning with the invivo5 software
-
3:49
updates on anti-amyloid monoclonal antibodies for ad in phase iii trials
-
22:01
3mensio ct pre-case planning: native tavr
-
2:20
updates from the circulate-us trial
-
7:21
how to...assemble dias iii
-
25:01
3mensio ct pre-case planning: redo-tavr with prior sapien 3 (1 of 2)
-
0:46
sequencing adcs and finding novel biomarkers for urothelial carcinoma